Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma

Hirofumi Kawakubo, S. Ozawa, N. Ando, Yuukou Kitagawa, M. Mukai, M. Ueda, M. Kitajima

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Many molecular alterations occur in esophageal carcinogenesis; however, little is known about the molecular genetic events responsible for the development of carcinoma. We investigated the expression of ki67, p53, cyclin D1 and pRB in 105 biopsy specimens using immunohistochemistry from iodine unstained lesions as indicators of carcinogenesis of the esophagus. Also, the genetic alternation of esophageal dysplasia from patients with accompanying esophageal squamous cell carcinoma (ESCC) was examined to study the evidence for field carcinogenesis in the esophagus. The expression of p53, cyclin D1 and pRB was detected in 31, 0 and 51.7% respectively of mild dysplasia; 40, 0 and 70% of moderate dysplasia; 40, 20 and 70% of severe dysplasia; and 48, 32 and 80% of carcinoma specimens. p53 expression was significantly increased in mild dysplasia, whereas cyclin D1 and pRB expression were significantly increased in carcinoma as compared to both normal epithelium and esophagitis. The ki67 LI and the rate of p53 expression were significantly higher in dysplasia with ESCC than in dysplasia without ESCC. Ki67, p53, cyclin D1 and pRB expression may be useful biomarkers for assessing the risk of developing esophageal cancer. Dysplasia observed at screening for secondary lesions has a highly malignant potential and careful follow-up studies are required.

Original languageEnglish
Pages (from-to)1453-1459
Number of pages7
JournalOncology Reports
Volume14
Issue number6
Publication statusPublished - 2005 Dec

Fingerprint

Cyclin D1
Carcinogenesis
Carcinoma
Esophagus
Esophagitis
Esophageal Neoplasms
Iodine
Molecular Biology
Epithelium
Biomarkers
Immunohistochemistry
Biopsy
Esophageal Squamous Cell Carcinoma

Keywords

  • cyclin D1
  • Dysplasia
  • Iodine unstained lesion
  • ki67
  • p53
  • pRB

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. / Kawakubo, Hirofumi; Ozawa, S.; Ando, N.; Kitagawa, Yuukou; Mukai, M.; Ueda, M.; Kitajima, M.

In: Oncology Reports, Vol. 14, No. 6, 12.2005, p. 1453-1459.

Research output: Contribution to journalArticle

Kawakubo, Hirofumi ; Ozawa, S. ; Ando, N. ; Kitagawa, Yuukou ; Mukai, M. ; Ueda, M. ; Kitajima, M. / Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma. In: Oncology Reports. 2005 ; Vol. 14, No. 6. pp. 1453-1459.
@article{a8a5cd0d19fa4cc0963522c82839a995,
title = "Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma",
abstract = "Many molecular alterations occur in esophageal carcinogenesis; however, little is known about the molecular genetic events responsible for the development of carcinoma. We investigated the expression of ki67, p53, cyclin D1 and pRB in 105 biopsy specimens using immunohistochemistry from iodine unstained lesions as indicators of carcinogenesis of the esophagus. Also, the genetic alternation of esophageal dysplasia from patients with accompanying esophageal squamous cell carcinoma (ESCC) was examined to study the evidence for field carcinogenesis in the esophagus. The expression of p53, cyclin D1 and pRB was detected in 31, 0 and 51.7{\%} respectively of mild dysplasia; 40, 0 and 70{\%} of moderate dysplasia; 40, 20 and 70{\%} of severe dysplasia; and 48, 32 and 80{\%} of carcinoma specimens. p53 expression was significantly increased in mild dysplasia, whereas cyclin D1 and pRB expression were significantly increased in carcinoma as compared to both normal epithelium and esophagitis. The ki67 LI and the rate of p53 expression were significantly higher in dysplasia with ESCC than in dysplasia without ESCC. Ki67, p53, cyclin D1 and pRB expression may be useful biomarkers for assessing the risk of developing esophageal cancer. Dysplasia observed at screening for secondary lesions has a highly malignant potential and careful follow-up studies are required.",
keywords = "cyclin D1, Dysplasia, Iodine unstained lesion, ki67, p53, pRB",
author = "Hirofumi Kawakubo and S. Ozawa and N. Ando and Yuukou Kitagawa and M. Mukai and M. Ueda and M. Kitajima",
year = "2005",
month = "12",
language = "English",
volume = "14",
pages = "1453--1459",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Alterations of p53, cyclin D1 and pRB expression in the carcinogenesis of esophageal squamous cell carcinoma

AU - Kawakubo, Hirofumi

AU - Ozawa, S.

AU - Ando, N.

AU - Kitagawa, Yuukou

AU - Mukai, M.

AU - Ueda, M.

AU - Kitajima, M.

PY - 2005/12

Y1 - 2005/12

N2 - Many molecular alterations occur in esophageal carcinogenesis; however, little is known about the molecular genetic events responsible for the development of carcinoma. We investigated the expression of ki67, p53, cyclin D1 and pRB in 105 biopsy specimens using immunohistochemistry from iodine unstained lesions as indicators of carcinogenesis of the esophagus. Also, the genetic alternation of esophageal dysplasia from patients with accompanying esophageal squamous cell carcinoma (ESCC) was examined to study the evidence for field carcinogenesis in the esophagus. The expression of p53, cyclin D1 and pRB was detected in 31, 0 and 51.7% respectively of mild dysplasia; 40, 0 and 70% of moderate dysplasia; 40, 20 and 70% of severe dysplasia; and 48, 32 and 80% of carcinoma specimens. p53 expression was significantly increased in mild dysplasia, whereas cyclin D1 and pRB expression were significantly increased in carcinoma as compared to both normal epithelium and esophagitis. The ki67 LI and the rate of p53 expression were significantly higher in dysplasia with ESCC than in dysplasia without ESCC. Ki67, p53, cyclin D1 and pRB expression may be useful biomarkers for assessing the risk of developing esophageal cancer. Dysplasia observed at screening for secondary lesions has a highly malignant potential and careful follow-up studies are required.

AB - Many molecular alterations occur in esophageal carcinogenesis; however, little is known about the molecular genetic events responsible for the development of carcinoma. We investigated the expression of ki67, p53, cyclin D1 and pRB in 105 biopsy specimens using immunohistochemistry from iodine unstained lesions as indicators of carcinogenesis of the esophagus. Also, the genetic alternation of esophageal dysplasia from patients with accompanying esophageal squamous cell carcinoma (ESCC) was examined to study the evidence for field carcinogenesis in the esophagus. The expression of p53, cyclin D1 and pRB was detected in 31, 0 and 51.7% respectively of mild dysplasia; 40, 0 and 70% of moderate dysplasia; 40, 20 and 70% of severe dysplasia; and 48, 32 and 80% of carcinoma specimens. p53 expression was significantly increased in mild dysplasia, whereas cyclin D1 and pRB expression were significantly increased in carcinoma as compared to both normal epithelium and esophagitis. The ki67 LI and the rate of p53 expression were significantly higher in dysplasia with ESCC than in dysplasia without ESCC. Ki67, p53, cyclin D1 and pRB expression may be useful biomarkers for assessing the risk of developing esophageal cancer. Dysplasia observed at screening for secondary lesions has a highly malignant potential and careful follow-up studies are required.

KW - cyclin D1

KW - Dysplasia

KW - Iodine unstained lesion

KW - ki67

KW - p53

KW - pRB

UR - http://www.scopus.com/inward/record.url?scp=33644675173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644675173&partnerID=8YFLogxK

M3 - Article

C2 - 16273238

AN - SCOPUS:33644675173

VL - 14

SP - 1453

EP - 1459

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -